-
Personalizing Lung Cancer Treatment Reduces Toxicity and Improves Cure Rates
08 May 2025 14:25 GMT
… population.3
New lung cancer treatment options have … NSCLC. Chemotherapy-free lung cancer treatment would be … effective.
Advancing Personalized Lung Cancer Treatment
Chemotherapy can cause … cetuximab for unresectable stage III non-small-cell lung cancer. …
-
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
20 Mar 2025 20:15 GMT
… NBTXR3) for patients with lung cancer (NSCLC) to be … presented at the 2025 European Lung Cancer Conference (“ELCC”). ABSTRACT … Locoregional Recurrent Non-Small Cell Lung Cancer (“NSCLC”)
Saumil J. … therapy, with or without cetuximab, for the treatment …
-
Design, Synthesis and Evaluation of Novel Cyclopropanesulfonamide Derivatives for the Treatment of EGFRC797S Mutation in Non-Small Cell Lung Cancer
27 Feb 2025 05:59 GMT
… cell lung cancer (NSCLC) and small cell lung cancer.1,2 … was combined with cetuximab,26 it demonstrated inhibitory … G, Pelosi E. Lung cancers: molecular characterization, clonal heterogeneity … non-small cell lung cancer (NSCLC). Lung Cancer. 2019;137:113 …
-
Frontline Fulzerasib Plus Cetuximab Elicits Deep, Durable Responses in KRAS G12C–Mutated NSCLC
28 Mar 2025 13:33 GMT
… fulzerasib (GFH925) and cetuximab (Erbitux) demonstrated efficacy with acceptable … advanced non–small cell lung cancer (NSCLC) harboring KRAS … during the 2025 European Lung Cancer Congress.1
At a … Presented at: 2025 European Lung Cancer Congress; March 26-29 …
-
NANOBIOTIX Announces First Patient Dosed in a New Randomized Phase 2 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
21 Jan 2025 07:30 GMT
… 3 unresectable non-small cell lung cancer receiving standard of care chemoradiation … study in non-small cell lung cancer brings us another step closer … radiation therapy, with or without cetuximab, for the treatment of patients …
-
The Targeted Pulse: Check Out Positive and Negative Updates in Head and Neck Cancer, and How the FDA is Handling Advancements in Lung Cancer Treatment
19 Jan 2025 19:53 GMT
… ), when compared with cetuximab (Erbitux), did not improve progression … the Fact Track for Lung Cancer Surgery
Injection abenacianine … existing deficits in lung cancer surgery by helping … [patients with] EGFR-positive lung cancer. These MARIPOSA results show …
-
Dermatologic Adverse Events Following Afatinib in a Woman with Non-Small-Cell Lung Cancer: A Case Report
17 Jan 2025 14:00 GMT
… , including non-small cell lung cancer (NSCLC), colorectal carcinoma ( … monoclonal antibodies (mAbs) (eg cetuximab, panitumumab, pertuzumab) and … during treatment of lung cancer and colorectal carcinoma … association and Taiwan Lung Cancer Society on the …
-
Krazati and Erbitux Combo Benefits KRAS G12C+ Metastatic Colorectal Cancer
20 Feb 2025 21:48 GMT
… with Krazati (adagrasib) to Erbitux (cetuximab) continued to show meaningful … makes Krazati combined with Erbitux a potential treatment … primarily for patients with lung cancer; however, we see … much more frequently in lung cancer. Subsequently, we were …
-
Frontline Eftilagimod Alpha/Pembrolizumab Yields Favorable OS in PD-L1–Negative HNSCC
05 May 2025 21:45 GMT
… of 10.7 months with cetuximab (Erbitux) plus chemotherapy, 11.3 months … /IV non–small cell lung cancer (NSCLC)with a PD-L1 … first line non-small cell lung cancer. News release. Immutep. October 4 … -first-line-non-small-cell-lung-cancer.html
-
Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR
05 May 2025 18:47 GMT
… previously treated non–small cell lung cancer (NSCLC),1-2 and … , from lower rates in lung cancer to higher shares in PDAC … and safety of adagrasib plus cetuximab in patients with KRASG12C- … patients with KRAS G12D-mutated lung cancer. News release. AACR. April …
About
© 1995-2025